You are here:

Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Metabolic conditions

Metabolic conditions Products

A list of all our products on metabolic conditions

Filter

Product type

Product typeGuidanceAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHighly specialised technologies guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Rebisufligene etisparvovec for treating mucopolysaccharidosis type IIIA ID6540
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
1 April 2026
Expected publication date:
TBC
Elamipretide for treating Barth syndrome in people of any age [ID6545]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
31 March 2026
Expected publication date:
TBC